Edwards Lifesciences
1,142 hedge funds and large institutions have $42.6B invested in Edwards Lifesciences in 2021 Q1 according to their latest regulatory filings, with 101 funds opening new positions, 432 increasing their positions, 364 reducing their positions, and 106 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
1% less funds holding
Funds holding: 1,157 → 1,142 (-15)
11% less capital invested
Capital invested by funds: $47.8B → $42.6B (-$5.25B)
44% less funds holding in top 10
Funds holding in top 10: 16 → 9 (-7)
Holders
1,142
Holding in Top 10
9
Calls
$105M
Puts
$74.6M
Top Buyers
| 1 | +$275M | |
| 2 | +$243M | |
| 3 | +$117M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$117M |
| 5 |
Sands Capital Management
Arlington,
Virginia
|
+$115M |
Top Sellers
| 1 | -$306M | |
| 2 | -$242M | |
| 3 | -$176M | |
| 4 |
Capital Research Global Investors
Los Angeles,
California
|
-$151M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$148M |